← Leaderboards
Chad Steele
Children'S Hosp Pittsburgh/Upmc Hlth Sys
$14,120,813
Attributed
$14,408,729
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,408,729 · 9
By mechanism
R01$13,611,769 · 7
R21$796,960 · 2
Top collaborators
- Paul L Fidel1 shared
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingResponseCellsLungCytokineProductionImmunityReporterSignal TransductionImmune ResponsePathway InteractionsAspergillus FumigatusGenerationsInfectionReportingHost DefenseIn VivoSourcePredispositionMediator Of Activation ProteinInflammatoryImmuneDectin 1In Vitro
Grant awards (43)
Immunopathogenesis in fungal asthma$454,849
R01 · FY2025 · HL · contact PI
Immunopathogenesis in fungal asthma$459,000
R01 · FY2024 · HL · contact PI
Biology of innate IL-22 during lung fungal infection$372,400
R01 · FY2024 · HL · contact PI
Candida mediated protection against polymicrobial sepsis$575,832
R01 · FY2023 · AI · contact PI
Immunopathogenesis in fungal asthma$490,633
R01 · FY2023 · HL · contact PI
Biology of innate IL-22 during lung fungal infection$380,000
R01 · FY2023 · HL · contact PI
Immunopathogenesis in fungal asthma$490,633
R01 · FY2022 · HL · contact PI
Biology of innate IL-22 during lung fungal infection$380,000
R01 · FY2022 · HL · contact PI
Immunopathogenesis in fungal asthma$490,633
R01 · FY2021 · HL · contact PI
Biology of innate IL-22 during lung fungal infection$380,000
R01 · FY2021 · HL · contact PI
Immunopathogenesis in fungal asthma$516,323
R01 · FY2020 · HL · contact PI
Biology of innate IL-22 during lung fungal infection$379,375
R01 · FY2020 · HL · contact PI
Biology of innate IL-22 during lung fungal infection$377,500
R01 · FY2019 · HL · contact PI
Biology of innate IL-22 during lung fungal infection$295,083
R01 · FY2018 · HL · contact PI
Immunopathogenesis in fungal asthma$226,506
R01 · FY2018 · HL · contact PI
Immunopathogenesis in fungal asthma$204,640
R01 · FY2018 · HL · contact PI
Biology of innate IL-22 during lung fungal infection$76,167
R01 · FY2018 · HL · contact PI
Immunopathogenesis in fungal asthma$431,146
R01 · FY2017 · HL · contact PI
Biology of innate IL-22 during lung fungal infection$371,250
R01 · FY2017 · HL · contact PI
Immunopathogenesis in fungal asthma$435,846
R01 · FY2016 · HL · contact PI
Adaptive immunity against Pneumocystis$367,500
R01 · FY2016 · HL · contact PI
Immunopathogenesis in fungal asthma$449,582
R01 · FY2015 · HL · contact PI
Adaptive immunity against Pneumocystis$361,987
R01 · FY2015 · HL · contact PI
Adaptive immunity against Pneumocystis$360,150
R01 · FY2014 · HL · contact PI
Pulmonary defense against aspergillus fumigatus$385,225
R01 · FY2013 · HL · contact PI
Adaptive immunity against Pneumocystis$349,760
R01 · FY2013 · HL · contact PI
Eosinophils and lung immunity to Pneumocystis$174,335
R21 · FY2013 · HL · contact PI
Pulmonary defense against aspergillus fumigatus$404,648
R01 · FY2012 · HL · contact PI
Eosinophils and lung immunity to Pneumocystis$219,750
R21 · FY2012 · HL · contact PI
STAT4 mediated immunity to Pneumocystis$183,125
R21 · FY2012 · HL · contact PI
Pulmonary defense against aspergillus fumigatus$408,735
R01 · FY2011 · HL · contact PI
STAT4 mediated immunity to Pneumocystis$219,750
R21 · FY2011 · HL · contact PI
Pulmonary defense against aspergillus fumigatus$17,703
R01 · FY2011 · HL · contact PI
Pulmonary defense against aspergillus fumigatus$366,250
R01 · FY2010 · HL · contact PI
Dectin-1 and Invasive Pulmonary Aspergillosis$366,250
R01 · FY2010 · AI · contact PI
Dectin-1 and Invasive Pulmonary Aspergillosis$365,833
R01 · FY2009 · AI · contact PI
Dectin-1 and Immunity Against Pneumocystis Carinii$303,919
R01 · FY2009 · HL · contact PI
Dectin-1 and Immunity Against Pneumocystis Carinii$73,250
R01 · FY2009 · HL · contact PI
Dectin-1 and Immunity Against Pneumocystis Carinii$303,919
R01 · FY2008 · HL · contact PI
Dectin-1 and Immunity Against Pneumocystis Carinii$283,725
R01 · FY2007 · HL · contact PI
Dectin-1 and Immunity Against Pneumocystis Carinii$17,252
R01 · FY2007 · HL · contact PI
Dectin-1 and Immunity Against Pneumocystis Carinii$309,965
R01 · FY2006 · HL · contact PI
Dectin-1 and Immunity Against Pneumocystis Carinii$328,300
R01 · FY2005 · HL